5 pending office actions • 1 client
| Client (Assignee) | Pending OAs |
|---|---|
| Revolution Medicines, Inc. | 5 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19388266 | Untitled | Revolution Medicines, Inc. | JARRELL, NOBLE E | 1699 | Non-Final OA | |
| 19308717 | Untitled | Revolution Medicines, Inc. | RZECZYCKI, PHILLIP MATTHEW | 1625 | Non-Final OA | |
| 18501211 | COVALENT RAS INHIBITORS AND USES THEREOF | Revolution Medicines, Inc. | LEESER, ERICH A | 1622 | Non-Final OA | Nov 03, 2023 |
| 18479500 | METHODS FOR INHIBITING RAS | Revolution Medicines, Inc. | LADD, CAROLYN LOUISE | 1622 | Non-Final OA | Oct 02, 2023 |
| 18011454 | METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS | Revolution Medicines, Inc. | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Dec 19, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial